Journal of pediatric surgery · 2026
Growth failure and early recurrence in congenital diaphragmatic hernia: An international cohort study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bordelon Rachel C, Holden Kylie I, Miller Charles C, Ebanks Ashley H, Lally Kevin P, Harting Matthew T, Speer Allison L, Representing the Congenital Diaphragmatic Hernia Study Group
Аннотация
PURPOSE: The primary objective was to determine whether growth failure (GF) is associated with early recurrence in congenital diaphragmatic hernia (CDH). The secondary objective was to characterize the prevalence and severity of GF in CDH survivors.
BACKGROUND: GF is common among CDH survivors, yet it is unclear how growth challenges affect overall morbidity, including hernia recurrence. CDH-specific nutritional guidelines include high calorie and protein targets during periods of acute illness but may benefit from clarifying the relationship between growth and adverse outcomes in this population.
METHODS: This multicenter cohort study retrospectively analyzed prospectively collected data from the CDH Study Group (CDHSG) registry. Weight-for-age Z-scores (WAZ) were calculated for CDH survivors born between 2007 and 2023 and GF was defined as WAZ <-2.0 at discharge from birth admission. Non-parametric tests and logistic regression analyses were employed.
RESULTS: Among 4931 CDH survivors, median gestational age and birth weight were 38 weeks and 3.1 kg, respectively (birth WAZ -0.24). Left-sided defects predominated (4205), with expected distribution by CDHSG stage: A (16 %), B (44 %), C (31 %), D (8 %). GF occurred in 14.6 % (720). Hernia recurrence occurred in 3.3 % (163), more commonly in those with GF: 6.4 % (46/720) versus 2.8 % (117/4211) (p < 0.001). GF patients had 80 % increased odds of early recurrence (adjusted odds ratio 1.8; 95 % CI 1.2-2.4; p = 0.007).
CONCLUSIONS: GF is a potentially modifiable risk factor for early CDH recurrence, underscoring the need for targeted nutritional protocols. Future studies should evaluate center-specific practices and assess long-term recurrence risk related to nutrition and growth.
BACKGROUND: GF is common among CDH survivors, yet it is unclear how growth challenges affect overall morbidity, including hernia recurrence. CDH-specific nutritional guidelines include high calorie and protein targets during periods of acute illness but may benefit from clarifying the relationship between growth and adverse outcomes in this population.
METHODS: This multicenter cohort study retrospectively analyzed prospectively collected data from the CDH Study Group (CDHSG) registry. Weight-for-age Z-scores (WAZ) were calculated for CDH survivors born between 2007 and 2023 and GF was defined as WAZ <-2.0 at discharge from birth admission. Non-parametric tests and logistic regression analyses were employed.
RESULTS: Among 4931 CDH survivors, median gestational age and birth weight were 38 weeks and 3.1 kg, respectively (birth WAZ -0.24). Left-sided defects predominated (4205), with expected distribution by CDHSG stage: A (16 %), B (44 %), C (31 %), D (8 %). GF occurred in 14.6 % (720). Hernia recurrence occurred in 3.3 % (163), more commonly in those with GF: 6.4 % (46/720) versus 2.8 % (117/4211) (p < 0.001). GF patients had 80 % increased odds of early recurrence (adjusted odds ratio 1.8; 95 % CI 1.2-2.4; p = 0.007).
CONCLUSIONS: GF is a potentially modifiable risk factor for early CDH recurrence, underscoring the need for targeted nutritional protocols. Future studies should evaluate center-specific practices and assess long-term recurrence risk related to nutrition and growth.